Boston Scientific Corporation (BSX) Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech, Inc.
3/3/2011 6:46:26 AM
More...
|
Boston Scientific Corporation (BSX) to Acquire Atritech, Inc.; Agreement Calls for Upfront Payment of $100M Plus Potential Payments of up to $275M
1/19/2011 6:50:00 AM
More...
|
Atritech, Inc. Enrolls First Patient Into PREVAIL Study
11/3/2010 6:48:23 AM
More...
|
Atritech, Inc. Announces FDA Regulatory Update
3/19/2010 11:12:24 AM
More...
|
Atritech, Inc. Announces FDA Regulatory Update; Confirmatory Study Required for Final FDA Approval
3/19/2010 7:00:31 AM
More...
|
FDA Advisory Panel Votes 7 To 5 To Recommend Approval Of Atritech, Inc.'s Watchman LAA Closure Device
4/23/2009 10:14:03 PM
More...
|
US FDA Staff Cites Issues With Atritech, Inc. Device Data
4/21/2009 5:44:51 PM
More...
|
Atritech, Inc. Completes $30 Million Financing
3/26/2009 9:23:35 AM
More...
|
Atritech, Inc. Files Pre-Market Approval Application for Its WATCHMAN(R) LAA Closure Technology Enrolls first patient in Continued Access Registry
8/18/2008 10:02:14 AM
More...
|
Atritech, Inc. Announces Completion of a $22 Million Equity Financing
9/5/2007 9:30:42 AM
More...
|
|